An exosome-based liquid biopsy signature for pre-operative identification of lymph node metastasis in patients with pathological high-risk T1 colorectal cancer.
Katsuki MiyazakiYuma WadaKeisuke OkunoTatsuro MuranoYuji MorineTetsuya IkemotoYu SaitoHiroaki IkematsuYusuke KinugasaMitsuo ShimadaAjay GoelPublished in: Molecular cancer (2023)
Our novel exosomal miRNA-based liquid biopsy signature robustly identifies T1 CRC patients at risk of LNM in a preoperative setting. This could be clinically transformative in reducing the significant overtreatment burden of this malignancy.